Your fact-checks

Your fact-checks will appear here

factually
Support us
  • Home
  • Politics
  • Business
  • Society
  • Technology
  • Health
  • Science
  • Entertainment
Index/Topics/Flibanserin approval

Flibanserin approval

Flibanserin was approved by the FDA for the treatment of female hypoactive sexual desire based on multiple 24-week, placebo-controlled trials.

Fact-Checks

1 result
Jan 29, 2026
Most Viewed

Are there head‑to‑head trials comparing bremelanotide, flibanserin, and testosterone for female low libido?

There are no published randomized, head‑to‑head clinical trials directly comparing , , and for ; the available evidence comes from separate placebo‑controlled trials, systematic reviews, and critiques...

About
Blog
Contact
FAQ
Terms & ConditionsTerms
Privacy PolicyPrivacy
Manage data